文献速递细菌感染、耐药与抗菌药物医院感染防控

综合内科病房强化碳青霉烯耐药肠杆菌预防项目的整群随机对照试验

Cluster-Randomized Controlled Trial of Enhanced Carbapenem-Resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital.
PubMed 文献 · Clin Infect Dis · 2026-01-01

在Siriraj医院6个综合内科病房开展整群随机对照试验,纳入363例有CRE危险因素的成人,比较标准感染控制与强化预防项目(含每月培训、实时通知和接触隔离提醒)。

要点

  • 强化CRE预防项目可能降低CRE获得发生率并延长无CRE生存时间。
  • 全因死亡率和住院时长两组无差异,需更大研究评估临床获益。

核心结论

  • 在资源有限环境下,强化CRE预防项目倾向于降低CRE获得并延长无CRE生存,但调整后未达统计学显著,对死亡和住院时长无影响。

主要发现

  • 全因死亡率和住院时长两组无差异。

临床怎么用

  • 在资源有限的内科病房,可考虑在标准感染控制基础上叠加员工教育、CRE获得实时通知和接触隔离提醒等强化措施。
  • 强化措施对硬终点(死亡、住院时长)的获益尚未证实,实施时需结合本地资源和CRE流行情况评估。

局限性

  • 样本量较小(363例、6个病房),累积发生率差异未达统计学显著。
  • 调整混杂后HR的95%CI跨越1,不能排除无效可能。
  • 全因死亡率和住院时长无差异,研究不足以评估发病率与死亡率获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) colonization is a major risk factor for infection. Most infection prevention and control (IPC) strategies rely on private-room isolation, but evidence of their effectiveness in resource-limited settings is scarce. METHODS: From February to October 2021, we conducted a cluster-randomized controlled trial in 6 general medical wards at Siriraj Hospital, enrolling adults with ≥1 CRE risk factor. Wards were randomized to standard infection control care (sIC) or an enhanced CRE prevention program (eIC) comprising sIC plus monthly staff education, real-time notifications of CRE acquisition, and contact-precaution reminders. Active stool/rectal CRE surveillance was performed at enrollment and weekly. Primary outcomes were the CRE acquisition incidence and CRE acquisition-free time. RESULTS: A total of 363 patients were included: 174 in the intervention group (1684 patient-days) and 189 in the control group (1517 patient-days). The cumulative incidence of CRE acquisition was slightly lower in the intervention group (36.8% vs 46.6%; P = .06), with a significantly lower incidence rate per patient-day (0.038 vs 0.058; P = .007). In a post hoc analysis excluding acquisitions within 24 hours, the cumulative incidence was similar between groups (25.7% vs 33.6%; P = .16). The probability of remaining CRE-free showed an unadjusted hazard ratio (HR) of 0.72 [95% CI, 0.52-1.00; P = .05]. After adjusting for prior antibiotic use, the adjusted HR was 0.75 [95% CI, 0.54-1.05; P = .09]. There were no differences in all-cause mortality or length of hospital stay. CONCLUSIONS: Carbapenem-resistant Enterobacterales acquisition incidence was high in this setting. The enhanced CRE prevention program tended to reduce CRE acquisition and prolong CRE-free survival. Larger studies are needed to explore benefits on morbidity and mortality.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Taweesuk A, Rattanaumpawan P, Rachakhom S, et al. Cluster-Randomized Controlled Trial of Enhanced Carbapenem-Resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital. Clin Infect Dis. 2026. PMID: 40982552. doi:10.1093/cid/ciaf523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。